Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products

Publication | Closed Access

DOI

Citations

References

2013

Year

Nahoko Uchiyama, Yoshihiko Shimokawa, Satoru Matsuda, Maiko Kawamura, Ruri Kikura‐Hanajiri, Yukihiro Goda

Forensic Toxicology

Cannabis UseMedicinal ChemistryIllegal ProductsPsychoactive DrugPharmacologyAm-2201 Benzimidazole AnalogDrug DevelopmentNew Synthetic CannabinoidsMedicineDrug ClassCannabinoidsDrug DiscoveryCannabis